PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1174545
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1174545
Single Use System in Biopharma Manufacturing Market size was valued at USD 3,084.7 Million in 2021, expanding at a CAGR of 23.8% from 2022 to 2028.
Fast-evolving technology called single-use systems is utilized for the creation of disposable bioprocessing machinery to produce biopharmaceutical goods. Different bioprocessing techniques as used in single-use biopharma manufacturing.
Due to the rising prevalence of chronic diseases in the population, there is an increase in the demand for biopharmaceuticals, which will likely lead to an increase in the demand for single-use technologies and further fuel the growth of the single-use system in the biopharma manufacturing market. For instance, the Food and Drug Administration reports that 14 biologics were authorized for the treatment of different chronic conditions in 2021. As a result, over the forecast period, it is anticipated that the growing number of biological approvals will raise the biopharmaceutical production process, which will increase the use and adoption of single-use bioprocessing technologies and systems.
Furthermore, a rise in funding for the creation of biologics including recombinant proteins, vaccines, and monoclonal antibodies is expected to boost the market growth. The adoption of single-use systems in the bioprocessing industry has also been aided by benefits related to their use, such as the large decrease in costs and time needed for operations and facility building. Additionally, the burden of disease is rising, and medicine and vaccination demand is rising globally. Additionally, an increase in demand for biopharmaceutical goods is anticipated to fuel market expansion. However, obstacles including high manufacturing costs and the need for high-end products are anticipated to impede expansion.
The Global Single-Use System in Biopharma Manufacturing Market is segmented on the basis of Product, Application, and Region.
The market is split into nine categories based on Product: bioprocess containers, bioreactors, mixers, membrane absorbers, sampling systems, equipment, bottles, transfer units, and others. The bioreactors segment dominates the market. Growing demand for different sized bioreactors is mainly contributing to segment growth.
The market is segmented into six categories based on application: cell culture, filtration, storage, mixing, purification, and aseptic filling. The filtration segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the demand for filtration systems in the pharma sector.
The worldwide market for Single Use Systems in Biopharma Manufacturing is highly fragmented with few large market players dominating the global market share. The companies in the market emphasize adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in April 2022, Merck KGaA announced an investment of nearly USD 105 million to accelerate its single-use manufacturing in China.
The scope of this report covers the market by its major segments, which include as follows: